Louisiana 2020 Regular Session

Louisiana House Bill HB616

Introduced
2/28/20  
Introduced
2/28/20  
Refer
2/28/20  
Refer
3/9/20  

Caption

Provides for disclosure of prescription drug cost information

Companion Bills

No companion bills found.

Previously Filed As

LA SB401

Provides for a Prescription Drug Affordability Board. (8/1/26)

LA SB0136

Disclosures related to prescription drugs.

LA A3406

Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

LA SB368

Provides for prescription drug pricing. (8/1/26) (OR +$270,360 SG EX See Note)

LA H0899

Insurer Disclosures on Prescription Drug Coverage

LA S1166

Insurer Disclosures on Prescription Drug Coverage

LA HB899

Insurer Disclosures on Prescription Drug Coverage:

LA SB1509

Relating To Prescription Drugs.

LA HB06870

An Act Addressing Patients' Prescription Drug Costs.

LA SB1509

Relating To Prescription Drugs.

Similar Bills

AZ HB2291

Opioids; containers; labeling; requirements; repeal

CA AB577

Health care coverage: antisteering.

RI H8318

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

RI S2889

Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.

HI HB2225

Relating To Health.

HI SB2751

Relating To Workers' Compensation.

RI H5866

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.

RI S0795

Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.